1. Accueil
  2. Contenus
  3. Dermatologie et trisomie 21 – introduction
  1. Accueil
  2. Contenus
  3. Dermatologie et trisomie 21 – introduction
Médical & paramédical

PATHOLOGIES DERMATOLOGIQUES

 

Dermatologie et trisomie 21 - introduction

Le docteur Hervé Walti, pédiatre à l’Institut Jérôme Lejeune, nous introduit, dans cette vidéo et dans la fiche technique qui l’accompagne, la dermatologie dans la trisomie 21.

 

Découvrez l’intégralité du chapitre « Pathologies dermatologiques » en cliquant sur “Plan du chapitre” à droite de l’image en haut de l’article.

Découvrez ci-dessous la présentation associée à cette vidéo.

  • Aase JM. The physical examination : Hands and feet – Minor variants ; in Aase JM (ed) : Diagnostic Dysmorphology. New York, Plenum Medical Book Co, 1990, pp 236–237.
  • Asen D. Secrets in fingerprints : clinical ambitions and uncertainty in dermatoglyphics. CMAJ. 2018 May 14;190(19):E597-E599.
  • Blok J, Jonkman M, Horváth B. The possible association of hidradenitis suppurativa and Down syndrome : is increased amyloid precursor protein expression resulting in impaired Notch signalling the missing link? Br J Dermatol. 2014 Jun;170(6):1375-7.
  • Bull MJ, Trotter T, Santoro SL, Christensen C, Grout RW; COUNCIL ON GENETICS; Burke LW, Berry SA, Geleske TA, Holm I, Hopkin RJ, Introne WJ, Lyons MJ, Monteil DC, Scheuerle A, Stoler JM, Vergano SA, Chen E, Hamid R, Downs SM, Grout RW, Cunniff C, Parisi MA, Ralston SJ, Scott JA, Shapira SK, Spire P. Health Supervision for Children and Adolescents With Down Syndrome. Pediatrics. 2022 May 1;149(5):e2022057010.
  • Carter DM, Jegasothy BV. Alopecia areata and Down syndrome. Arch Dermatol. 1976 Oct;112(10):1397-9.
  • Contaldo M, Lucchese A, Romano A, Della Vella F, Di Stasio D, Serpico R, Petruzzi M. Oral Microbiota Features in Subjects with Down Syndrome and Periodontal Diseases: A Systematic Review. Int J Mol Sci. 2021 Aug 26;22(17):9251.
  • Cummins H. Dermatoglyphic stigmata in mongoloid imbeciles. Anat Rec 1939;73:407-15.
  • Cummins H, Talley C, Platou RV. Palmar dermatoglyphics in mongolism. Pediatrics 1950;5:241-8.
  • Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M. Mucocutaneous findings in 100 children with Down syndrome. Pediatr Dermatol. 2007 May-Jun;24(3):317-20.
  • Real de Asua D, Quero M, Moldenhauer F, Suarez C. Clinical profile and main comorbidities of Spanish adults with Down syndrome. Eur J Intern Med. 2015 Jul;26(6):385-91.
  • Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 1996 Nov;50(5):317-20.
  • Fölster-Holst R, Rohrer T, Jung AM. Dermatological aspects of the S2k guidelines on Down syndrome in childhood and adolescence. J Dtsch Dermatol Ges. 2018 Oct;16(10):1289-1295.
  • Frisoli ML, Essien K, Harris JE. Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol. 2020 Apr 26;38:621-648.
  • Fitzpatrick V, Rivelli A, Chaudhari S, Chicoine L, Jia G, Rzhetsky A, Chicoine B. Prevalence of infectious diseases among 6078 individuals with Down syndrome in the United States. J Patient Cent Res Rev. 2022;9:64-9.
  • Herzog V, Kirfel G, Siemes C, Schmitz A. Biological roles of APP in the epidermis. Eur J Cell Biol. 2004 Dec;83(11-12):613-24.
  • von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol. 1998 Mar;91(3):319-23.
  • Kanbara Y, Takeuchi C, Mochizuki Y, Osako M, Sasaki M, Miyake H. Medical Needs of Adults with Down Syndrome Presenting at a Regional Medical and Rehabilitation Center in Japan. J Nippon Med Sch. 2023 May 30;90(2):210-219.
  • Kato Y, Yamamoto T. Eruptive collagenoma in a juvenile patient with Down syndrome. An Bras Dermatol. 2022 Sep-Oct;97(5):687-688.
  • Määttä T, Määttä J, Tervo-Määttä T, Taanila A, Kaski M, Iivanainen M. Healthcare and guidelines: a population-based survey of recorded medical problems and health surveillance for people with Down syndrome. J Intellect Dev Disabil. 2011 Jun;36(2):118-26.
  • Malle L, Patel RS, Martin-Fernandez M, Stewart OJ, Philippot Q, Buta S, Richardson A, Barcessat V, Taft J, Bastard P, Samuels J, Mircher C, Rebillat AS, Maillebouis L, Vilaire-Meunier M, Tuballes K, Rosenberg BR, Trachtman R, Casanova JL, Notarangelo LD, Gnjatic S, Bush D, Bogunovic D. Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c+ B cells. Nature. 2023 Mar;615(7951):305-314.
  • Patel D, Li P, Bauer AJ, Castelo-Soccio L. Screening Guidelines for Thyroid Function in Children With Alopecia Areata. JAMA Dermatol. 2017 Dec 1;153(12):1307-1310.
  • Pikora TJ, Bourke J, Bathgate K, Foley KR, Lennox N, Leonard H. Health conditions and their impact among adolescents and young adults with Down syndrome. PLoS One. 2014 May 12;9(5):e96868.
  • PNDS: Trisomie 21, HAS 2020. Téléchargeable sur www.has-sante.fr
  • Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol. 2018 Nov;179(5):1033-1048.
  • Reed TE, Borgaonkar DS, Conneally PM, Yu P, Nance WE, Christian JC, et al. Dermatoglyphic nomogram for the diagnosis of Down’s syndrome. J Pediatr 1970;77:1024-32.
  • Rork JF, McCormack L, Lal K, Wiss K, Belazarian L. Dermatologic conditions in Down syndrome: A single-center retrospective chart review. Pediatr Dermatol. 2020 Sep;37(5):811-816.
  • Ryan C, Vellody K, Belazarian L, Rork JF. Dermatologic conditions in Down syndrome. Pediatr Dermatol. 2021 Nov;38 Suppl 2:49-57.
  • Schepis C, Romano C. Cutaneous findings in the mentally retarded. Int J Dermatol. 1996 May;35(5):317-22.
  • Schepis C, Barone C, Siragusa M, Pettinato R, Romano C. An updated survey on skin conditions in Down syndrome. Dermatology. 2002;205(3):234-8.
  • Sokoloff A, Dykman M, Sokoloff G, Vellody K, Holland K, Rork J. If my hidradenitis had a voice, this is what it would say: the perspective of a young woman with Down syndrome and hidradenitis suppurativa. Br J Dermatol. 2023 Jul 17;189(2):221-222
  • Sureshbabu R, Kumari R, Ranugha S, Sathyamoorthy R, Udayashankar C, Oudeacoumar P. Phenotypic and dermatological manifestations in Down Syndrome. Dermatol Online J. 2011 Feb 15;17(2):3.
  • Tazi-Ahnini R, di Giovine FS, McDonagh AJ, Messenger AG, Amadou C, Cox A, Duff GW, Cork MJ. Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region. Hum Genet. 2000 Jun;106(6):639-45.
  • Vigarios E, de Bataille C, Boulanger M, Fricain JC, Sibaud V. Variations physiologiques de la langue [Normal variations in lingual soft tissue]. Ann Dermatol Venereol. 2015 Oct;142(10):583-92; quiz 581-2, 593-4. French.
  • Wentworth AB, Hand JL, Davis DM, Tollefson MM. Skin concerns in patients with trisomy 21 (Down syndrome): A Mayo Clinic 22-year retrospective review. Pediatr Dermatol. 2021 Nov;38 Suppl 2:73-78.
Thématiques : Médical & paramédical

Contenus Similaires

Voir tous les contenus

Inscrivez-vous

Pour recevoir notre newsletter et rester informé des nouveaux contenus, inscrivez-vous !

        Institut Jérôme Lejeune
        37 rue des Volontaires
        75015 PARIS

        Institut Jérôme Lejeune
        37 rue des Volontaires 75015 PARIS

        Suivez l’actualité de
        l’Institut Jérôme Lejeune sur nos réseaux

        Suivez l’actualité de l’Institut
        Lejeune sur nos réseaux

         Votre inscription a bien été prise en compte